Ketamine Completed Phase 2 Trials for Depression / Post Traumatic Stress Disorder (PTSD) / Anxiety Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00749203Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
NCT02106325Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients
NCT01880593Ketamine Plus Lithium in Treatment-Resistant Depression